Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2018-05-29 AGM Information
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
PCI Biotech: Minutes from Annual General Meeting 2018
AGM Information Classification · 98% confidence The document title explicitly states 'Minutes from Annual General Meeting 2018'. The text confirms that the Annual General Meeting took place and that 'Minutes from the Annual General Meeting are attached.' Although the content is the minutes, the document itself is a very short announcement (895 chars) stating that the minutes are attached, which strongly suggests it is an announcement of the AGM materials rather than the full minutes document itself. However, given the specific definition for AGM-R ('Presentations and materials shared during the Annual General Meeting (AGM)'), and the fact that minutes are core AGM material, AGM-R is the most appropriate classification, even if it is presented as an announcement wrapper. If 'RPA' were chosen, it would miss the specific AGM context. Since the content is directly about the AGM proceedings and outcomes (approvals, board members), AGM-R is prioritized over RPA.
2018-05-29 English
PCI Biotech: Disclosure of voting rights for Chairman of the Board
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is a 'Disclosure of voting rights for Chairman of the Board' and details the number of shares held directly and the number of shares represented via powers of attorney specifically for the upcoming 'annual general meeting'. This content directly relates to the voting structure and representation at a shareholder meeting, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category, although this specific document is a pre-meeting disclosure of voting power rather than the final results. However, given the options, DVA (Declaration of Voting Results & Voting Rights Announcements) is the most relevant category concerning voting rights disclosure for a general meeting. It is not a general Director's Dealing (DIRS) as it focuses on voting power for the AGM, not general trading. It is also not AGM-R as it is a regulatory disclosure about voting rights, not the meeting presentation itself.
2018-05-28 English
PCI Biotech initiates research collaboration with IMV Inc
Regulatory Filings Classification · 95% confidence The document announces a specific business event: a research collaboration initiated between PCI Biotech and IMV Inc. It details the nature of the agreement (preclinical research collaboration), the technologies involved, and includes quotes from the CEO. This type of announcement, detailing strategic partnerships, collaborations, or significant operational developments that are not standard financial reports (like 10-K, ER, or IR), typically falls under general regulatory announcements or news releases. Since there is no specific category for 'Collaboration Announcement' and it is not a standard financial filing, it is best classified as a general Regulatory Filing (RNS), which serves as a broad category for material news releases not covered elsewhere. It is too specific for a general 'LTR' (Legal) or 'CAP' (Financing). Given the context of a material business development announcement, RNS is the most appropriate fit.
2018-05-24 English
PCI Biotech to present at BioEquity Europe
Regulatory Filings Classification · 100% confidence The document is a short announcement from PCI Biotech stating that the company will present at an investor and partnering event (BioEquity Europe). It details the date, time, and location of the presentation, and mentions that the presentation overview will be made available on the company's website under 'News'. Since the document is short (3181 characters) and primarily serves to announce the upcoming presentation and where materials will be found, it fits the definition of a Report Publication Announcement (RPA) or potentially a general Regulatory Filing (RNS). Given the specific nature of announcing the publication/availability of presentation materials, RPA is the most precise fit, as per Rule 2 (The 'MENU VS MEAL' Rule). It is not the presentation itself (IP), nor a full earnings release (ER).
2018-05-15 English
PCI Biotech: Notice of Annual General Meeting 2018
Board/Management Information Classification · 98% confidence The document is titled "Innstilling fra Valgkomitéen i PCI Biotech Holding ASA" (Proposal from the Nomination committee of PCI Biotech Holding ASA) dated May 7, 2018. It discusses the board composition and the work done by the nomination committee regarding board elections. This content directly relates to the composition and selection of the board of directors and senior management. Therefore, it aligns best with the Board/Management Information category (MANG).
2018-05-08 English
PCI Biotech: Notice of Annual General Meeting 2018
AGM Information Classification · 100% confidence The document text explicitly contains the Norwegian phrase "INNKALLING TIL ORDINÆR GENERALFORSAMLING" and the English translation "NOTICE OF ORDINARY GENERAL MEETING". It details the time, place, and a numbered agenda for a general meeting, including items like the approval of annual accounts (Item 5) and the election of the board (Item 6). This content is characteristic of a formal notice sent to shareholders convening an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2018-05-08 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.